Medifast Inc. (MED)

77.25
NYSE : Retail Trade
Prev Close 76.61
Day Low/High 76.90 / 78.58
52 Wk Low/High 66.50 / 162.57
Avg Volume 384.40K
Exchange NYSE
Shares Outstanding 11.62M
Market Cap 889.85M
EPS 4.70
P/E Ratio 12.60
Div & Yield 3.00 (3.75%)
Medifast Getting Very Oversold (MED)

Medifast Getting Very Oversold (MED)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Medifast Inc Breaks Below 200-Day Moving Average - Notable For MED

Medifast Inc Breaks Below 200-Day Moving Average - Notable For MED

In trading on Thursday, shares of Medifast Inc crossed below their 200 day moving average of $26.65, changing hands as low as $25.94 per share. Medifast Inc shares are currently trading down about 4.7% on the day.

5 Stocks Poised for Breakouts

5 Stocks Poised for Breakouts

These stocks look ready to break out and trade higher from current levels.

Bullish Two Hundred Day Moving Average Cross - MED

Bullish Two Hundred Day Moving Average Cross - MED

In trading on Tuesday, shares of Medifast Inc crossed above their 200 day moving average of $26.23, changing hands as high as $26.30 per share. Medifast Inc shares are currently trading up about 2.1% on the day.

Medifast CEO: Meal Replacement = Big Growth

Medifast CEO: Meal Replacement = Big Growth

Medifast CEO Mike MacDonald expects 19% growth in the meal replacement business.

A New Year Resolution Stocks List For Long Term Investing Ideas

A New Year Resolution Stocks List For Long Term Investing Ideas

New Year Resolutions are a money-making machine. At the top of the resolution list is ⿿lose wight,⿝ ⿿get organized,⿝ ⿿quit [...]

Not Sold on the Uptrend

Not Sold on the Uptrend

After last Friday's follow-through, the action has been unconvincing.

Stocks Deliver Election Day Rally

Stocks Deliver Election Day Rally

The Dow gains ground for a second straight session as investors await the results of the U.S. presidential race.

The Week Ahead: Earnings Schmearnings

The Week Ahead: Earnings Schmearnings

While these reports should offer clarity, the election will clear a much bigger overhang on the market.

Weight Loss Pills Not a Threat, Says Medifast CEO

Weight Loss Pills Not a Threat, Says Medifast CEO

Mike MacDonald, CEO of Medifast, says the company's new franchise strategy is propelling its stock and recently approved weight loss pills are not a threat.

A Supplemental Strategy

A Supplemental Strategy

Plenty of activity in the nutritional-supplements industry today.

A Stirring Performance From These Small-Caps

A Stirring Performance From These Small-Caps

These under-the-radar stocks have done very well of late, and they have the fundamentals to back it up.

Sifting Through Small-Caps for Acquisition Targets

Sifting Through Small-Caps for Acquisition Targets

Bank of America Merrill Lynch expects deal activity to pick up in the small-cap space in 2012 with tech and health care seen as the most popular sectors.

Wellness Is Word of the Day at ICR XChange

Wellness Is Word of the Day at ICR XChange

Companies like lululemon and Jamba are cashing in on the trend toward getting healthy,

NYSE Stocks Posting Largest Percentage Increases

NYSE Stocks Posting Largest Percentage Increases

Top 10 New York Stock Exchange-traded stocks posting largest percentage increases

Medifast Inc. Stock Upgraded (MED)

Medifast Inc. Stock Upgraded (MED)

Medifast (NYSE:MED) has been upgraded by TheStreet Ratings from a hold to buy.

NYSE Stocks Posting Largest Percentage Decreases

NYSE Stocks Posting Largest Percentage Decreases

Top 10 New York Stock Exchange-traded stocks posting largest percentage decreases

Bernstein Liebhard LLP Announces That Less Than A Week Remains To Make A Lead Plaintiff Motion In Medifast Class Action

Bernstein Liebhard LLP Announces That Less Than A Week Remains To Make A Lead Plaintiff Motion In Medifast Class Action

Bernstein Liebhard LLP today announced that the deadline to make a lead plaintiff motion in the Medifast class action is May 17, 2011.

Medifast Rises On Unusually High Volume (MED)

Medifast Rises On Unusually High Volume (MED)

Medifast (NYSE:MED) is trading at unusually high volume Tuesday with 2.5 million shares changing hands. It is currently at four times its average daily volume and trading up $3.18 (+15.6%).

Medifast Inc. Stock Downgraded (MED)

Medifast Inc. Stock Downgraded (MED)

Medifast (NYSE:MED) has been downgraded by TheStreet Ratings from from a buy to hold.

Today's Outrage: Skeptics Missing at SEC

Today's Outrage: Skeptics Missing at SEC

Smaller companies threaten, bully and sue their critics, and the regulator takes no action.

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Medifast, Inc.

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Medifast, Inc.

Ryan & Maniskas, LLP ( www.rmclasslaw.

The Shuman Law Firm Announces The Filing Of A Class Action Lawsuit Against Medifast, Inc.

The Shuman Law Firm Announces The Filing Of A Class Action Lawsuit Against Medifast, Inc.

The Shuman Law Firm today announced that a class action lawsuit has been filed in the United States District Court for the District Maryland on behalf of a class (the “Class”) of investors who purchased...

Medifast, Inc. Investigation Prompts Proposed Class Action Lawsuit By Goldfarb Branham Law Firm LLP

Medifast, Inc. Investigation Prompts Proposed Class Action Lawsuit By Goldfarb Branham Law Firm LLP

Upon news that Medifast, Inc. (NYSE: MED) is delaying its fiscal 2010 annual fiscal results, Goldfarb Branham LLP is investigating possible violations of shareholder protection laws by the company’s board.

Faruqi & Faruqi, LLP Investigates Potential Wrongdoing At Medifast Inc. - MED

Faruqi & Faruqi, LLP Investigates Potential Wrongdoing At Medifast Inc. - MED

Faruqi & Faruqi, LLP, a national law firm concentrating on investors rights, consumer rights and enforcement of federal antitrust laws, is investigating potential wrongdoing at Medifast Inc.

The Briscoe Law Firm Investigates Medifast, Inc. On Behalf Of Shareholders For Possible Breaches Of Fiduciary Duties By Its Officers And Directors

The Briscoe Law Firm Investigates Medifast, Inc. On Behalf Of Shareholders For Possible Breaches Of Fiduciary Duties By Its Officers And Directors

The Briscoe Law Firm, PLLC, founded by a former state prosecutor and enforcement attorney for the United States Securities and Exchange Commission, and the securities law firm of Powers Taylor, LLP are...

Bernstein Liebhard LLP Announces Filing Of A Class Action Against Medifast, Inc.

Bernstein Liebhard LLP Announces Filing Of A Class Action Against Medifast, Inc.

Bernstein Liebhard LLP today announced that a lawsuit has been filed in the United States District Court for the District of Maryland on behalf of a class (the “Class”) of investors who purchased Medifast, Inc.

The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Securities Laws Violations By Medifast, Inc. -- MED

The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Securities Laws Violations By Medifast, Inc. -- MED

Levi & Korsinsky is investigating potential claims on behalf of purchasers of the securities of Medifast, Inc.

Medifast Rises On Unusually High Volume (MED)

Medifast Rises On Unusually High Volume (MED)

Medifast (NYSE:MED) is trading at unusually high volume Monday with 1.4 million shares changing hands. It is currently at four times its average daily volume and trading up $1.59 (+9.6%).

TheStreet Quant Rating: B- (Buy)